Therapeutic targeting of a microRNA to treat Duchenne muscular dystrophy
US11236336B2 · kind B2 · utility
0Cited by
2References
29Claims
0Family size
Assignees
Inventors
Key dates
| Filing date | Mar 24, 2020 |
| Grant date | Feb 1, 2022 |
| Priority date | — |
| Expiry date | Mar 24, 2040 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC12N2320/35
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Methods of treating Duchenne muscular dystrophy (DMD) and Becker muscular dystrophy (BMD), comprising administering an inhibitory nucleic acid that targets miR-128.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.